Table 1.
Some recent patents issued for the discovery of miRNA molecules throughout the word.
| Patent No. | Patent Type (Country of Origin) | Publication Date | Patent Statement | Inventors | Applicant |
|---|---|---|---|---|---|
| US 20,170,240,898 A1 | US Patent | 10th March 2016 | Method for inhibiting Ebola virus via miRNA | Chenyu Zhang et al. | Jiangsu Micromedmark Biotech Co., Ltd (Taizhou, Jiangsu, CN) |
| US 20,180,171,334 A1 | US Patent | 21st June 2018 | Targeting microRNAs for metabolic disorders | BalkrishenBhat et al. | Regulus Therapeutics Inc. (San Diego, CA.USA) |
| US 20,170,121,711 A1 | US Patent | 4th May 2017 | miRNAs useful for identifying targets associated with cancer | Olorunseun O. Ogunwobi and Dibash K. Das | Research Foundation of the City University of New York (New York, NY,USA) |
| US 20,150,126,579 A1 | US Patent | 7th May 2015 | Micro-RNA inhibitors and their uses in disease | Pier Paolo Pandolfi et al. | Beth Israel Deaconess Medical Center (Boston, MA,USA) |
| CA3024953 A1 | European Patent | 11th October 2007 | Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides | ElmenJoacim et al. | Roche Innovation Ct Copenhagen As |
| KR20180112180A | Korean Patent | 12th October 2018 | miRNA DNA DNA structure for validation of miRNA target | RyuSeong Ho and Choi Cheol Won | Soonchunhyang University Industry Academy Cooperation Foundation |
| WO2018181877 A1 | Japan Patent | 4th October 2018 | Cancer stem cell growth inhibitor using miRNA | Xin Wu et al. | Cancer Stem Tech Inc, Japan |
| US2018251858A1 | US Patent | 6th September 2018 | Method for identification of anti-HIV human miRNA mimics and miRNA inhibitors and anti-HIV pharmaceutical compounds | JerolenNaidoo et al. | CSIR [ZA] |
| WO2018157026A1 | US Patent | 30th August 2018 | Treatment of tumors with miRNA targeting CDK4/CDK6 | Amriti R Lulla and Wafik S EL-Deiry | Institute for Cancer Research and The Research Institute of Fox Chase Cancer Center, USA |
| CN108456692 A | China Patent | 28th August 2018 | Quadruple miRNA for resisting foot and mouth disease virus infection and building method | Jing Chen et al. | Institute of Animal Health, Guangdong Academy Agricultural Sciences,China |
| US2018223277 A1 | US Patent | 9th August 2018 | New Precursor miRNA and Applications in Tumor Therapy there of | Chenyu Zhang et al. | Jiangsu Micromedmark Biotech Co Ltd,China |
| CN108452307 A | China Patent | 28th August 2018 | Application of human miRNA-493-3p inhibitor in preparing medicine for treating renal fibrosis | Rui Du et al. | The Fourth Military Medical University, China |
| WO2018187673 A1 | US Patent | 11th October 2018 | miRNA signature expression in cancer | Marie Wood et al. | University of Vermont and State Agricultural College,USA |
| WO2018165929A1 | US Patent | 20th September 2018 | Dual miRNA inhibitory expression vector, construction method and application thereof | Jiyan Mao | Shenzhen Biocan Tech Co LTD, China |
| CA3012344A1 | US Patent | 17th August 2017 | Anti-AngiogenicmiRNA therapeutics for inhibiting corneal neovascularization | GuangpingGaoet al. | University Massachusetts, USA |
| CN108324946A | China Patent | 27th July 2018 | Application of miRNA708 and/or 301-cluster miRNA in the aspect of improving cardiac function | Zuoren Yu et al. | Shanghai East Hospital, China |
| CN108283646A | China Patent | 17th July 2018 | Application of hsa-miRNA-155-5p for preparing medicine for inhibiting human enterovirus 71 | Lingxiang Mao et al. | Zhenjiang First Peoples Hospital, China |